RecruitingNot ApplicableNCT06350851

Development of a New Rapid Diagnostic Test to Support Onchocerciasis Elimination


Sponsor

Bioaster

Enrollment

400 participants

Start Date

Apr 15, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Onchocerciasis, also known as river blindness, is one of the disease targeted for elimination by the World Health Organization (WHO) in the group of Neglected Tropical Diseases. Existing diagnostic tools for onchocerciasis have limitations that make mapping, epidemiological assessments and verification of elimination of onchocerciasis difficult. It is in this context that WHO, in its 2021-2030 roadmap for onchocerciasis, has identified the development of new diagnostic tests, or the improvement of existing diagnostic tests, as a critical condition for achieving the goal of eliminating onchocerciasis transmission. To this end, a series of cross-sectional studies will be carried out in Cameroun over a one year period to collect and characterize biological samples for the development and evaluation of a new rapid diagnostic test for onchocerciasis. The study will target individuals aged 18 and over, mono-infected with one of the filarial species Onchocerca volvulus, Loa loa or Mansonella perstans; and non-infected. At the end of this study, data on the endemicity of onchocerciasis, loiasis and mansonellosis in the selected communities will be updated. More importantly, a new rapid diagnostic test will be developed, which can then be used to monitor the activities of onchocerciasis control programs.


Eligibility

Min Age: 18 Years

Inclusion Criteria5

  • Subjects informed of the objectives of the study and who signed a consent form
  • Subjects without filariasis (for control subjects), or
  • Subjects mono-infected with Onchocerca volvulus, or
  • Subjects mono-infected with Loa loa, or
  • Subjects mono-infected with Mansonella perstans or alternatively co-infected with Mansonella perstans and Loa loa

Exclusion Criteria2

  • Pregnant or breast-feeding women
  • Subjects having taken antihelminthic treatment less than 6 months before the inclusion date

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BIOLOGICALBiological samples collection (blood drawing + feces)

Blood and feces samples will be collected from each volunteer.


Locations(1)

Higher Institute for Scientific and Medical Research

Yaoundé, Cameroon

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06350851


Related Trials